OpenNeedle Ask your own

Question explored with the scientific record

Answered on this page ↓

Are there strategies to reduce appetite or water gain while tapering?

Oct 24, 2026 · 5 sources used · OpenNeedle synthesis
The short version: the appetite and water gain you are asking about are side effects of the pregabalin, and the records here say nothing about strategies to counter them during a taper. There is no study to lean on.

Nothing in this set tests diet, salt restriction, movement, or any tactic against appetite or fluid retention during pregabalin tapering. The one case series describes withdrawal symptoms that included loss of appetite, not gain [4]. The dose studies that list weight gain and swelling as side effects are about being on the drug, not coming off it [2][3].

Here is what the records do establish, and where it bites. Weight gain was reported in about 24 in 100 people on long-term pregabalin in one open-label study [3], and peripheral swelling in about 9 in 100 across pooled trials, versus about 4 in 100 on placebo [2]. Long-term use also showed fluid retention among side effects [3]. All of that was on the drug. The same records never measured what happens to weight or water as the dose falls.

EffectOn pregabalinOff it (taper)
Weight gainreported [2][3]not measured
Swelling/fluidreported [2][3]not measured
Appetite strategiesnone testednone tested

There is a real caution hidden in this. Withdrawal itself can bring nausea, headache, and loss of appetite [4][5], and cutting too fast is what the records warn against [1]. So the practical move is a slow taper done with your prescriber, not a home remedy aimed at the scale.

My call: no record here supports any specific appetite or water strategy during tapering, so treat any tactic as untested and keep the taper gradual. Confidence: not clear.

Keep digging

Sources used 5

  1. Psychiatric Symptoms Following Sudden Withdrawal from the Drug Pregabalin International Archives of Addiction Research and Medicine (2024) commentary Mixed

    Doctors and pharmacy staff should be aware that psychiatric symptoms may occur after sudden withdrawal from pregabalin, even in standard-dose patients; doses should be tapered rather than stopped suddenly.

    DOI: 10.23937/2474-3631/1510044
  2. A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain Pain Practice (2013) Thin

    This Pfizer-sponsored analysis pooled patient-level data from 31 randomized trials of pregabalin in peripheral neuropathic pain to characterize the incidence and timing of adverse events, compare across doses and disease conditions, and advocate careful dose titration to maximiz…

    DOI: 10.1111/papr.12146
  3. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability Current Medical Research and Opinion (2013) Thin

    This study evaluates the long-term safety and tolerability of pregabalin in patients with generalized anxiety disorder (GAD), social anxiety disorder (SAD), or panic disorder (PD) over a one-year open-label treatment period, finding it generally well tolerated with sustained imp…

    DOI: 10.1185/03007995.2013.820694
  4. Pregabalin withdrawal in patients without psychiatric disorders taking a regular dose of pregabalin: A case series and literature review Neuropsychopharmacology Reports (2021) primary study Strong

    Three patients without psychiatric or substance-use disorders developed withdrawal symptoms after abrupt reduction or discontinuation of regular-dose pregabalin, and symptoms improved after resuming pregabalin; a literature review found six similar published cases.

    DOI: 10.1002/npr2.12195
  5. Pregabalin‐withdrawal encephalopathy and splenial edema: A link to high‐altitude illness? Annals of Neurology (2005) other Strong

    In an 80-year-old woman without epilepsy, abrupt pregabalin discontinuation was followed by nausea, headache, ataxia and delirium, with reversible splenial MRI edema resembling high-altitude cerebral edema.

    DOI: 10.1002/ana.20583

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →